NSE BSE
medico remedies limited stock

MEDICO REMEDIES LIMITED Share Price

- - (%)
Sector: -

9673

540937

MEDICO

img img img img
No Data Available

MEDICO REMEDIES LIMITED : Share Price Update


As of the latest trading session, MEDICO REMEDIES LIMITED share price is currently at 39.3, which is down by -1.15 from its previous closing. Today, the stock has fluctuated between 38.55 and 40.45. Over the past year, MEDICO REMEDIES LIMITED has achieved a return of -51.76 %. In the last month alone, the return has been -14.27 %.

MEDICO REMEDIES LIMITED Performance

Day Range

Low38.55 High40.45
39.30

52 Week Range

Low 36.70 High 100.70
39.30

Open Price

40.45

Prev. Close

40.45

Volume (Shares)

182041.00

Total traded value

71.54

Upper Circuit

42.45

Lower Circuit

38.45

Note: The current prices & values are delayed, Login to your account for live updates.

MEDICO REMEDIES LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 326.10
PE Ratio (TTM) 40.44
Book Value / Share 6.31
Beta 0.38
ROE 18.00%
EPS (TTM) 1.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) 3.10

MEDICO REMEDIES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 41.32
Operating Expense 37.67
Net Profit 3.10
Net Profit Margin (%) 7.50
Earnings Per Share (EPS) 0.37
EBITDA 5.24
Effective Tax Rate (%) 27.05
Particulars DEC 2023 (Values in Cr)
Revenue 29.77
Operating Expense 27.98
Net Profit 1.45
Net Profit Margin (%) 4.87
Earnings Per Share (EPS) 0.17
EBITDA 3.00
Effective Tax Rate (%) 30.09
Particulars SEP 2023 (Values in Cr)
Revenue 42.36
Operating Expense 40.17
Net Profit 2.43
Net Profit Margin (%) 5.73
Earnings Per Share (EPS) 0.29
EBITDA 4.03
Effective Tax Rate (%) 22.92
Particulars JUN 2023 (Values in Cr)
Revenue 31.47
Operating Expense 29.90
Net Profit 1.32
Net Profit Margin (%) 4.19
Earnings Per Share (EPS) 0.16
EBITDA 2.76
Effective Tax Rate (%) 29.78
Particulars MAR 2023 (Values in Cr)
Revenue 27.99
Operating Expense 25.76
Net Profit 1.77
Net Profit Margin (%) 6.32
Earnings Per Share (EPS) 0.21
EBITDA 3.21
Effective Tax Rate (%) 22.46
Particulars MAR 2024 (Values in Cr)
Revenue 144.92
Operating Expense 135.70
Net Profit 8.29
Net Profit Margin (%) 5.72
Earnings Per Share (EPS) 1.00
EBITDA 15.03
Effective Tax Rate (%) 26.83
Particulars MAR 2023 (Values in Cr)
Revenue 140.44
Operating Expense 134.29
Net Profit 7.24
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 0.87
EBITDA 13.57
Effective Tax Rate (%) 28.31
Particulars MAR 2022 (Values in Cr)
Revenue 121.02
Operating Expense 116.56
Net Profit 4.81
Net Profit Margin (%) 3.97
Earnings Per Share (EPS) 2.90
EBITDA 9.36
Effective Tax Rate (%) 25.77
Particulars MAR 2021 (Values in Cr)
Revenue 122.39
Operating Expense 119.73
Net Profit 2.59
Net Profit Margin (%) 2.11
Earnings Per Share (EPS) 6.25
EBITDA 6.26
Effective Tax Rate (%) 29.53
Particulars MAR 2020 (Values in Cr)
Revenue 88.64
Operating Expense 88.52
Net Profit 1.63
Net Profit Margin (%) 1.83
Earnings Per Share (EPS) 3.93
EBITDA 4.94
Effective Tax Rate (%) 26.12
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 18.00
ROCE % 21.01
Total Debt to Total Equity 0.28
EBITDA Margin 9.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.04
ROE % 13.93
ROCE % 14.74
Total Debt to Total Equity 0.40
EBITDA Margin 7.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.22
ROE % 8.31
ROCE % 10.11
Total Debt to Total Equity 0.46
EBITDA Margin 5.12
Particulars MAR 2020 (Values in Cr)
Book Value / Share 71.98
ROE % 5.61
ROCE % 7.64
Total Debt to Total Equity 0.47
EBITDA Margin 5.57
Particulars MAR 2019 (Values in Cr)
Book Value / Share 68.05
ROE % 5.72
ROCE % 7.75
Total Debt to Total Equity 0.47
EBITDA Margin 4.78
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.17
Total Assets 87.44
Total Liabilities 87.44
Total Equity 43.84
Share Outstanding 82984000
Price to Book Ratio 14.15
Return on Assets (%) 8.28
Return on Capital (%) 13.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 77.40
Total Liabilities 77.40
Total Equity 36.57
Share Outstanding 16596800
Price to Book Ratio 3.81
Return on Assets (%) 6.21
Return on Capital (%) 10.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.83
Total Assets 75.62
Total Liabilities 75.62
Total Equity 32.46
Share Outstanding 4149200
Price to Book Ratio 1.28
Return on Assets (%) 3.42
Return on Capital (%) 5.45
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 75.26
Total Liabilities 75.26
Total Equity 29.86
Share Outstanding 4149200
Price to Book Ratio 1.02
Return on Assets (%) 2.16
Return on Capital (%) 3.91
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 76.30
Total Liabilities 76.30
Total Equity 28.23
Share Outstanding 4149200
Price to Book Ratio 1.25
Return on Assets (%) 2.05
Return on Capital (%) 3.84
Particulars MAR 2023 (Values in Cr)
Net Income 10.09
Cash from Operations 10.66
Cash from Investing -6.60
Cash from Financing -1.81
Net change in Cash -0.25
Free Cash Flow 10.66
Particulars MAR 2022 (Values in Cr)
Net Income 6.48
Cash from Operations 7.65
Cash from Investing -1.75
Cash from Financing -5.77
Net change in Cash -1.66
Free Cash Flow 7.65
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations -10.38
Cash from Investing -16.96
Cash from Financing 18.28
Net change in Cash -9.99
Free Cash Flow 6.58
Particulars MAR 2020 (Values in Cr)
Net Income 2.21
Cash from Operations 1.54
Cash from Investing -3.08
Cash from Financing 2.59
Net change in Cash 0.48
Free Cash Flow 3.48
Particulars MAR 2019 (Values in Cr)
Net Income 2.17
Cash from Operations 5.53
Cash from Investing -4.43
Cash from Financing -0.55
Net change in Cash -0.04
Free Cash Flow 8.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 109.15 11.93 1.18 1142.70 71.00 / 148.95
CIPLA LTD 1420.05 26.93 4.29 114654.12 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 160.95 0.00 1.65 473.69 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2023.85 53.46 22.26 34285.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8570.70 34.79 19.44 19738.32 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
MEDICO REMEDIES LIMITED 40.44 40.44 6.40 335.59 36.45 / 100.79
AMRUTAJAN HEALTH LTD 749.30 49.23 8.26 2166.27 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5639.25 88.39 21.52 14098.13 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.15 15.08 1.15 1142.70 71.00 / 148.95
ABBOTT INDIA LIMITED 26545.40 46.96 15.25 56408.98 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 40.40
  • 26 Days 44.20
  • 10 Days 41.90
  • 50 Days 54.40
  • 12 Days 42.20
  • 100 Days 64.90
  • 20 Days 43.70
  • 200 Days 79.20
40.32
PIVOT
First Resistance 41.63
Second Resistance 42.82
Third Resistance 44.13
First Support 39.13
Second Support 37.82
Third Support 36.63
RSI 29.14
MACD -2.08
Commodity Channel Index (CCI) -112.58
ADX 61.48
Williams % R -64.62

Over 1 Month

down

-14.27

Over 3 Months

down

-51.12

Over 6 Months

down

-48.88

Over 1 Year

down

-51.76

Over 3 Years

down

0.00

Over 5 Years

down

0.00

MEDICO REMEDIES LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MEDICO REMEDIES LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.37
Promoter Holdings
73.33
FII
0.29
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Haresh Kapurlal Mehta Shareholding of Promoter and Promoter Group 1.72292E7 20.76
Rishit Hareshbhai Mehta Shareholding of Promoter and Promoter Group 1.23E7 14.82
Harshit Haresh Mehta Shareholding of Promoter and Promoter Group 9520000.0 11.47
Rita H Mehta Shareholding of Promoter and Promoter Group 8628000.0 10.4
Shweta Harshit Mehta Shareholding of Promoter and Promoter Group 7260000.0 8.75
Priyal Rishit Mehta Shareholding of Promoter and Promoter Group 5200000.0 6.27
Ravi Goyal (huf) . Public Shareholding 3275000.0 3.95
Vijaygopal Parasram Atal Public Shareholding 1728000.0 2.08
Escorp Asset Management Limited Public Shareholding 1473000.0 1.78
Sanjay Narendra Bansal Public Shareholding 1248000.0 1.5
Harshit H Mehta Huf Shareholding of Promoter and Promoter Group 720000.0 0.87
Haresh K Mehta Huf Shareholding of Promoter and Promoter Group 0.0 0.0

MEDICO REMEDIES LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
2021-11-17 2021-11-16 3:1
Ex-Date Old FV NEW FV Record Date
2023-03-16 10.0 2.0 2023-03-16

Learn More About Stocks

About MEDICO REMEDIES LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MEDICO REMEDIES LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Medico Remedies Ltd?

Answer Field

The share price of Medico Remedies Ltd for NSE is ₹ 39.3 and for BSE is ₹ 39.68.

What is the Market Cap of Medico Remedies Ltd?

Answer Field

The market cap of Medico Remedies Ltd for NSE is ₹ 326.10 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Medico Remedies Ltd?

Answer Field

The 52 Week High and Low of Medico Remedies Ltd for NSE is ₹ 100.70 and ₹ 36.70 and for BSE is ₹ 100.79 and ₹ 36.45.

How to Buy Medico Remedies Ltd share?

Answer Field

You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medico Remedies Ltd?

Answer Field

The 1 year returns on the stock has been -52.57%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader